Laquinimod
- Generic Name
- Laquinimod
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C19H17ClN2O3
- CAS Number
- 248281-84-7
- Unique Ingredient Identifier
- 908SY76S4G
- Background
Laquinimod is an immunomodulator developed by Active Biotech and produced by Teva Pharmaceutical Industries. It is currently under development in phase III trials for treatment of multiple sclerosis as an oral therapy, like fingolimod. It has been shown to reduce disease activity on magnetic resonance imaging and to be well tolerated orally.
- Indication
Investigated for use/treatment in multiple sclerosis.
- Associated Conditions
- -
- Associated Therapies
- -
No news found
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath